Cargando…

Evaluation of Inhibitory Action of Novel Non β-Lactam Inhibitor against Klebsiella pneumoniae Carbapenemase (KPC-2)

The use of three classical β-lactamase inhibitors (Clavulanic acid, tazobactam and sulbactam) in combination with β-lactam antibiotics is presently the mainstay of antibiotic therapy against Gram-negative bacterial infections. However these inhibitors are unable to inhibit carbapenemase KPC-2 effect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khan, Arbab, Faheem, Mohammad, Danishuddin, Mohd, Khan, Asad U.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180753/ https://www.ncbi.nlm.nih.gov/pubmed/25265157 http://dx.doi.org/10.1371/journal.pone.0108246

Ejemplares similares

Biochemical Characterization of CTX-M-15 from Enterobacter cloacae and Designing a Novel Non-β-Lactam-β-Lactamase Inhibitor
por: Faheem, Mohammad, et al.
Publicado: (2013)

Correction: Biochemical Characterization of CTX-M-15 from Enterobacter cloacae and Designing a Novel Non-β-Lactam-β-Lactamase Inhibitor
por: Faheem, Mohammad, et al.
Publicado: (2013)

Overview of the epidemiology and the threat of Klebsiella pneumoniae carbapenemases (KPC) resistance
por: Chen, Luke F, et al.
Publicado: (2012)

In vitro Combined Inhibitory Activities of β-Lactam Antibiotics and Clavulanic Acid Against bla(KPC-2)-Positive Klebsiella pneumoniae
por: Peng, Mingjia, et al.
Publicado: (2021)

Chromosomal Integration of the Klebsiella pneumoniae Carbapenemase Gene, bla(KPC), in Klebsiella Species Is Elusive but Not Rare
por: Mathers, Amy J., et al.
Publicado: (2017)

Emergence of Klebsiella pneumoniae clinical isolates producing KPC-2 carbapenemase in Cuba
por: Quiñones, D, et al.
Publicado: (2014)

Genomic epidemiology of global Klebsiella pneumoniae carbapenemase (KPC)-producing Escherichia coli
por: Stoesser, N., et al.
Publicado: (2017)

Carbapenemase producing Klebsiella pneumoniae (KPC) meningitis from chronic otitis media
por: Anwar, Shamsuddin, et al.
Publicado: (2020)

The Effect of β-Lactam Antibiotics on the Evolution of Ceftazidime/Avibactam and Cefiderocol Resistance in KPC-Producing Klebsiella pneumoniae
por: Zhang, Ping, et al.
Publicado: (2023)

Genomic Characterization of KPC-31 and OXA-181 Klebsiella pneumoniae Resistant to New Generation of β-Lactam/β-Lactamase Inhibitor Combinations
por: Muresu, Narcisa, et al.
Publicado: (2022)

Genomic Epidemiology of an Endoscope-Associated Outbreak of Klebsiella pneumoniae Carbapenemase (KPC)-Producing K. pneumoniae
por: Marsh, Jane W., et al.
Publicado: (2015)

Poor Sensitivity of the MALDI Biotyper(®) MBT Subtyping Module for Detection of Klebsiella pneumoniae Carbapenemase (KPC) in Klebsiella Species
por: Cuello, Luz, et al.
Publicado: (2023)

In vitro activity of the β-lactamase inhibitor NXL104 against KPC-2 carbapenemase and Enterobacteriaceae expressing KPC carbapenemases
por: Stachyra, Thérèse, et al.
Publicado: (2009)

Molecular Characterization of Klebsiella pneumoniae Carbapenemase (KPC)-Producing Enterobacteriaceae in Ontario, Canada, 2008-2011
por: Tijet, Nathalie, et al.
Publicado: (2014)

Carbapenemase Producing Klebsiella pneumoniae (KPC): What Is the Best MALDI-TOF MS Detection Method
por: Hleba, Lukáš, et al.
Publicado: (2021)

Distribution of β-Lactamase Genes and Genetic Context of bla(KPC-2) in Clinical Carbapenemase-Producing Klebsiella pneumoniae Isolates
por: Liu, Hongmao, et al.
Publicado: (2021)

Klebsiella pneumoniae Carbapenemase (KPC)–Producing K. pneumoniae Contamination of an In-Room Sink in a New Bed Tower
por: Warren, Bobby, et al.
Publicado: (2021)

Emergence of Carbapenemase Producing Klebsiella Pneumonia and Spread of KPC-2 and KPC-17 in Taiwan: A Nationwide Study from 2011 to 2013
por: Tseng, I-Ling, et al.
Publicado: (2015)

Isolation of a Klebsiella pneumoniae Isolate of Sequence Type 258 Producing KPC-2 Carbapenemase in Korea
por: Roh, Kyoung Ho, et al.
Publicado: (2011)

Treatment of Klebsiella Pneumoniae Carbapenemase (KPC) infections: a review of published case series and case reports
por: Lee, Grace C, et al.
Publicado: (2012)

Inhibitory effect of zingiber officinale towards Streptococcus mutans virulence and caries development: in vitro and in vivo studies
por: Hasan, Sadaf, et al.
Publicado: (2015)

New Carbapenemase Inhibitors: Clearing the Way for the β-Lactams
por: Vázquez-Ucha, Juan C., et al.
Publicado: (2020)

A Multicenter Case-Case–control Study of Factors Associated with Klebsiella pneumoniae Carbapenemase (KPC)-Producing Enterobacteriaceae (KPC-CRE) Infections in Children
por: Nguyen, David C, et al.
Publicado: (2017)

Genomic analysis and antimicrobial activity of β-lactam/β-lactamase inhibitors and other agents against KPC-producing Klebsiella pneumoniae clinical isolates from Brazilian hospitals
por: Camargo, Carlos Henrique, et al.
Publicado: (2023)

In Vivo Pharmacodynamics of β-Lactams/Nacubactam against Carbapenem-Resistant and/or Carbapenemase-Producing Enterobacter cloacae and Klebsiella pneumoniae in Murine Pneumonia Model
por: Hagihara, Mao, et al.
Publicado: (2021)

Quantitative Insights Into β-Lactamase Inhibitor’s Contribution in the Treatment of Carbapenemase-Producing Organisms With β-Lactams
por: Feng, Yanfang, et al.
Publicado: (2021)

Virulence of Klebsiella pneumoniae Isolates Harboring bla (KPC-2) Carbapenemase Gene in a Caenorhabditis elegans Model
por: Lavigne, Jean-Philippe, et al.
Publicado: (2013)

Antimicrobial activity evaluation and comparison of methods of susceptibility for Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacter spp. isolates
por: Rechenchoski, Daniele Zendrini, et al.
Publicado: (2017)

Risk factors for Klebsiella pneumoniae carbapenemase (KPC) gene acquisition and clinical outcomes across multiple bacterial species
por: Mathers, A.J., et al.
Publicado: (2020)

Natural variants modify Klebsiella pneumoniae carbapenemase (KPC) acyl–enzyme conformational dynamics to extend antibiotic resistance
por: Tooke, Catherine L., et al.
Publicado: (2020)

Screening of inhibitors for S130G inhibitor resistant mutants of TEM type beta-lactamase
por: Baig, Mohd Hassan, et al.
Publicado: (2012)

Klebsiella pneumoniae Carbapenemase (KPC)-Producing K. pneumoniae at a Single Institution: Insights into Endemicity from Whole-Genome Sequencing
por: Mathers, Amy J., et al.
Publicado: (2015)

Longitudinal Comparison of the Microbiota During Klebsiella pneumoniae Carbapenemase-Producing Klebsiella pneumoniae (KPC-Kp) Acquisition in Long-Term Acute Care Hospital (LTACH) patients
por: Seekatz, Anna, et al.
Publicado: (2017)

Relationship between adverse drug reactions to antibacterial agents and the Klebsiella pneumoniae carbapenemase-producing (KPC) Klebsiella pneumoniae outbreak: insight from a pharmacovigilance study
por: Gatti, Milo, et al.
Publicado: (2019)

Klebsiella pneumoniae Carbapenemase, Canada
por: Pillai, Dylan R., et al.
Publicado: (2009)

Carbapenemase-producing Klebsiella pneumoniae
por: Robilotti, Elizabeth, et al.
Publicado: (2014)

Identification of Klebsiella pneumoniae that produces β-Lactamase bla(KPC )gene
por: Sá Queiroz, Julio Henrique Ferreira de, et al.
Publicado: (2014)

National Surveillance Study on Carbapenem Non-Susceptible Klebsiella pneumoniae in Taiwan: The Emergence and Rapid Dissemination of KPC-2 Carbapenemase
por: Chiu, Sheng-Kang, et al.
Publicado: (2013)

Cost-effectiveness analysis of vaborem for the treatment of carbapenem-resistant Enterobacteriaceae-Klebsiella pneumoniae carbapenemase (CRE-KPC) infections in the UK
por: Vlachaki, Ioanna, et al.
Publicado: (2021)

2558. Predicting β-Lactam Resistance Using Whole Genome Sequencing (WGS) in Klebsiella pneumoniae: The Challenge of β-Lactam Inhibitors
por: Hujer, Andrea, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_dfm0eu1bfrnpg0hqr3767qre13